Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail L Jones

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Blood Advances|May 24, 2018
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductaseSarah E Fordham, Helen J Blair, Claire J Elstob, et al.
JCI Insight|December 8, 2022
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.
Nature Communications|January 5, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Blood|January 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Blood Advances|May 24, 2018
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductaseSarah E Fordham, Helen J Blair, Claire J Elstob, et al.
JCI Insight|December 8, 2022
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.
Nature Communications|January 5, 2022
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.
Blood|January 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.
Pageof 2